Disease | acute myocardial infarction |
Phenotype | C0011849|diabetes mellitus |
Sentences | 8 |
PubMedID- 23226370 | Although clinical outcomes of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) is well established to be worse than non-diabetic patients [1], [2], the reasons for this remain unclear. |
PubMedID- 21393298 | Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. |
PubMedID- 26279482 | Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy. |
PubMedID- 24843443 | Furthermore, anemia is accompanied by cardiovascular events9–12, mortality13 and mortality after acute myocardial infarction16 in patients with diabetes mellitus. |
PubMedID- 24399329 | Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus. |
PubMedID- 20484611 | Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone. |
PubMedID- 24529823 | Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus. |
PubMedID- 26209521 | Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus. |
Page: 1